WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced a national distribution agreement with DJO Global for the SENSUS™ Pain Management
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq:NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced the launch of www.DPNCheck.com . The website is an important online resource that will
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, has been featured in several media outlets that spotlighted the Company and the SENSUS ™ Pain
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced that Jiro Nakamura , M.D., Ph.D., has joined its Scientific Advisory Board . Dr.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today previewed its unaudited financial highlights for the fourth quarter ended December 31, 2013 .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, announced that it had entered into an agreement with Omron Medical Devices, a subsidiary of Omron Healthcare China, to
NeuroMetrix to Present at 7th Annual OneMedForum: Investing in Healthcare 2014 WALTHAM, Mass. --(BUSINESS WIRE)--Dec. 4, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.SENSUS Rx .com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today
NeuroMetrix Launches www.SENSUSRx.com WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 22, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, announced the launch of www.SENSUS Rx .com .
NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 7, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the treatment and management of the neurological complications of diabetes,
